UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 68 filers reported holding UNIQURE NV in Q1 2018. The put-call ratio across all filers is 0.07 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $453,000 | -37.3% | 67,530 | +7.2% | 0.00% | – |
| Q2 2023 | $722,000 | -38.2% | 62,988 | +8.6% | 0.00% | – |
| Q1 2023 | $1,168,000 | -16.3% | 57,980 | -5.8% | 0.00% | – |
| Q4 2022 | $1,395,000 | +6.2% | 61,567 | -12.1% | 0.00% | – |
| Q3 2022 | $1,313,000 | -1.3% | 70,012 | -1.9% | 0.00% | – |
| Q2 2022 | $1,330,000 | -1.6% | 71,391 | -4.5% | 0.00% | – |
| Q1 2022 | $1,351,000 | -6.2% | 74,770 | +7.7% | 0.00% | – |
| Q4 2021 | $1,440,000 | -37.5% | 69,442 | -3.5% | 0.00% | -100.0% |
| Q3 2021 | $2,303,000 | -3.1% | 71,955 | -6.8% | 0.00% | 0.0% |
| Q2 2021 | $2,377,000 | -6.0% | 77,205 | +2.9% | 0.00% | 0.0% |
| Q1 2021 | $2,528,000 | -7.3% | 75,018 | -0.6% | 0.00% | 0.0% |
| Q4 2020 | $2,727,000 | +1004.0% | 75,479 | +1026.7% | 0.00% | – |
| Q3 2020 | $247,000 | -4.3% | 6,699 | +17.3% | 0.00% | – |
| Q2 2020 | $258,000 | +40.2% | 5,711 | +47.4% | 0.00% | – |
| Q1 2020 | $184,000 | -20.3% | 3,874 | +20.0% | 0.00% | – |
| Q4 2019 | $231,000 | +4.5% | 3,229 | -42.3% | 0.00% | – |
| Q3 2019 | $221,000 | -53.4% | 5,601 | -7.8% | 0.00% | – |
| Q2 2019 | $474,000 | +43.2% | 6,075 | +9.7% | 0.00% | – |
| Q1 2019 | $331,000 | +6520.0% | 5,539 | +3158.2% | 0.00% | – |
| Q4 2018 | $5,000 | -54.5% | 170 | -43.5% | 0.00% | – |
| Q3 2018 | $11,000 | -71.1% | 301 | -70.0% | 0.00% | – |
| Q2 2018 | $38,000 | +3700.0% | 1,005 | +1832.7% | 0.00% | – |
| Q4 2017 | $1,000 | -90.0% | 52 | -94.8% | 0.00% | – |
| Q3 2017 | $10,000 | +25.0% | 1,004 | -20.8% | 0.00% | – |
| Q2 2017 | $8,000 | +14.3% | 1,267 | -0.5% | 0.00% | – |
| Q1 2017 | $7,000 | 0.0% | 1,273 | +0.5% | 0.00% | – |
| Q4 2016 | $7,000 | -30.0% | 1,267 | 0.0% | 0.00% | – |
| Q3 2016 | $10,000 | +11.1% | 1,267 | 0.0% | 0.00% | – |
| Q2 2016 | $9,000 | -40.0% | 1,267 | 0.0% | 0.00% | – |
| Q1 2016 | $15,000 | -11.8% | 1,267 | +26.7% | 0.00% | – |
| Q4 2015 | $17,000 | -15.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2015 | $20,000 | -25.9% | 1,000 | 0.0% | 0.00% | – |
| Q2 2015 | $27,000 | -89.0% | 1,000 | -90.1% | 0.00% | – |
| Q1 2015 | $245,000 | +1533.3% | 10,100 | +910.0% | 0.00% | – |
| Q4 2014 | $15,000 | +66.7% | 1,000 | 0.0% | 0.00% | – |
| Q3 2014 | $9,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
| Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
| 683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
| PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
| Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
| Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
| Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
| Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
| Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |